Affymetrix Announces Federal Court Affirms Dismissal of Illumina Patent Infringement Lawsuits
August 19 2011 - 6:00AM
Business Wire
Affymetrix, Inc. (NASDAQ:AFFX) (the “Company”) today announced
that the U. S. Court of Appeals for the Federal Circuit has
affirmed the dismissal of the patent infringement lawsuits brought
against the Company by Illumina regarding U.S. Patent Nos.
7,510,841 and 7,612,020.
“We are pleased that the Federal Circuit has affirmed the
District Court’s prior rulings that Affymetrix does not infringe
the asserted patents and dismissing Illumina’s lawsuits,” said Rick
Runkel, Affymetrix's Executive Vice President, General Counsel and
Secretary. “As we said at the outset of this process, we are
committed to conducting our business with the utmost integrity and
believe the ruling of both the District Court and the Court of
Appeals underscore this commitment.”
About Affymetrix
Affymetrix technology is used by the world's top pharmaceutical,
diagnostic, and biotechnology companies, as well as leading
academic, government, and nonprofit research institutes. More than
23,700 peer-reviewed papers have been published using the
technology. Affymetrix is headquartered in Santa Clara, Calif., and
has manufacturing facilities in Santa Clara, Cleveland, Ohio, and
Singapore. The company has about 900 employees worldwide and
maintains sales and distribution operations across Europe, Asia,
and Latin America. For more information about Affymetrix, please
visit http://www.affymetrix.com.
Forward-Looking Statements
All statements in this press release that are not historical are
“forward-looking statements” within the meaning of Section 21E of
the Securities Exchange Act as amended, including statements
regarding Affymetrix’s “expectations,” “beliefs,” “hopes,”
“intentions,” “strategies” or the like. Such statements are subject
to risks and uncertainties that could cause actual results to
differ materially for Affymetrix from those projected. These and
other risk factors are discussed in Affymetrix’ Form 10-K for the
year ended December 31, 2010, and other SEC reports for subsequent
quarterly periods.
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2023 to Jul 2024
